About EPIRUS

EPIRUS Biopharmaceuticals (Nasdaq: EPRS) is a biopharmaceutical company building a focused, sustainable and profitable biosimilar company by improving patient access to important, cost-effective medicines worldwide.

Facts about EPIRUS
  • Focus : Manufacturer
  • Industry : Biotechnology

Here you will find EPIRUS Biopharmaceuticals

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world
Topic world Antibodies

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous